Director/PDMR Shareholding

RNS Number : 5732I

Spire Healthcare Group PLC

31 August 2016

 

31 August 2016

Spire Healthcare Group plc (the "Company")

On 30 August 2016, the following Directors exercised the second tranche of their vested Directors' Share Bonus Plan awards (the "Awards") over ordinary shares in the Company.  The Awards were granted in the form of nil-cost options to Simon Gordon and Garry Watts on 4 July 2014, prior to the Company's Admission to the London Stock Exchange.

Based on the average share price on the second anniversary of Admission, the Awards partially vested and became exercisable on 23 July 2016.

Director	Type of award	Shares vested and exercised	Shares sold*	Shareholding following transaction
Simon Gordon	Conditional Share Award (in the form of nil-cost options)	195,427	92,174	471,758
Garry Watts		227,991	107,533	503,577

*All shares sold were at an average share price of 350.4 pence.

Both Directors sold sufficient shares to cover their Income Tax and NIC liabilities and then retained the balance of their Awards.

Further details regarding the Awards are provided within the Company's 2015 Directors' Remuneration Report.

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Simon Gordon
2	Reason for the notification
a)	Position/status	Executive Director and Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	n/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each
b)	Nature of the transaction	Exercise of a nil-cost share option over 195,427 shares granted under the Company's Deferred Bonus Plan and subsequent sale of 92,174 shares stemming from such exercise.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		350.4 pence	92,174
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2016-08-30
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Garry Watts
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	n/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each
b)	Nature of the transaction	Exercise of a share option over 227,991 shares granted under the Company's Deferred Bonus Plan and subsequent sale of 107,533 shares stemming from such exercise.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		350.4 pence	107,533
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2016-08-30
f)	Place of the transaction	XLON

Enquiries:

Philip Davies

Deputy Company Secretary

020 7427 9092

 

END

 

 

DSHBBGDILSXBGLB